CARGILL SLU
CARGILL SLU (Spain) holds 1 active US FDA Type II Drug Master File and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “CARGILL SLU: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/cargill-slu
Overview
CARGILL SLU is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering C* PHARMDEX 02010 (GLUCOSE MONOHYDRATE).
Core services & business areas
API / Drug Master Files
CARGILL SLU holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- C* PHARMDEX 02010 (GLUCOSE MONOHYDRATE)Active2017-11-07
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to CARGILL SLU, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to CARGILL SLU in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this CARGILL SLU?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.